Vaccination rate increased, HPV even significantly For the first time in five years, the number of children receiving vaccinations from the National Immunisation Programme has increased slightly.
Radioactive substances in the air over Northern Europe In the first half of June 2020, small amounts of artificial (man-made) radioactive substances have been detected at several measuring stations in Northern Europe.
Corona crisis has limited impact on infant participation in National Immunisation Programme Nearly all infants in the Netherlands are still participating in the National Immunisation Programme.
A pregnant woman can protect her baby against whooping cough with 22-week vaccination From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.
Towards a sustainable, healthy future for everyone: EU project INHERIT offers policy solutions Today, on 10 December a policy toolkit will be presented at the final conference of the European four-year research project INHERIT.
Report on the developments of the National Immunisation Programme: stabilisation of participation and low level of disease In the first six months of 2019, the number of notified meningococcal serogroup W (MenW) disease cases decreased in almost all age groups, after a continuous increase since 2015.
Affirmation of collaboration between Public Health England and RIVM On Thursday 11 April 2019, RIVM welcomed a delegation from Public Health England (PHE). Chief Executive Duncan Selbie of PHE headed the delegation.
Article in The Lancet Infectious Diseases on RIVM research into Maternal pertussis vaccination Scientific journal The Lancet Infectious Diseases has published an article on RIVM research conducted into pertussis vaccination for pregnant women.